Studies have also found that immune cell infiltration within the tumor microenvironment was associated with favorable outcome in patients with GC [17, 46], and that the antitumor activity of IL-25 in tumor-bearing mouse models stimulated the infiltration of eosinophils into tumor site and activation of B cells [30, 47]. The gene discussed is IL25; the disease is gastric cancer.